[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100590807":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":10,"centralContacts":18,"locations":24,"responsibleParty":50,"collaborators":10,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":60,"eligibilityCriteria":61,"healthyVolunteers":56,"sex":62,"minAge":63,"maxAge":10,"enrollmentInfo":64,"targetDuration":10,"studyType":67,"phases":10,"briefSummary":68,"conditions":69,"keywords":10,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Laval University","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":11},"DEB",null,[12],"Device: DEB",[14],{"type":15,"name":9,"description":16,"armGroupLabels":17,"otherNames":10},"DEVICE","Use of DEB to treat coronary lesions",[9],[19],{"name":20,"role":21,"phone":22,"phoneExt":10,"email":23},"Michele Jadin","CONTACT","418-6568711","michele.jadin@criucpq.ulaval.ca",[25],{"facility":26,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"IUCPQ","RECRUITING","Québec","Quebec","G1V4G5","Canada","CA",{"type":34,"coordinates":35},"Point",[36,37],-71.21454,46.81228,{"lat":37,"lon":36},[40,42,45,48],{"name":20,"role":21,"phone":41,"phoneExt":10,"email":23},"418-656-8711",{"name":43,"role":44,"phone":10,"phoneExt":10,"email":10},"Olivier F. Bertrand, MD, PhD","PRINCIPAL_INVESTIGATOR",{"name":46,"role":47,"phone":10,"phoneExt":10,"email":10},"Tomas A. Cieza, MD","SUB_INVESTIGATOR",{"name":49,"role":47,"phone":10,"phoneExt":10,"email":10},"Andres R.A. Ruhl, MD",{"type":51,"investigatorFullName":52,"investigatorTitle":53,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Olivier F. Bertrand","MD, PhD","100590807","restrospective-analysis-of-mace-in-patients-treated-with-drug-elluting-balloons-100590807",false,"NCT06972225","Restrospective Analysis of MACE in Patients Treated With Drug-elluting Balloons.","Follow-up of MACE in Patients Treated With Drug-eluting Balloons Between 2010 and 2025; a Retrospective Study With Prospective Follow-up From an Institutional Database: EASY-drug-eluting Balloons","EASY-DEB","Inclusion Criteria:\n\n* Adults (\\>=18 years of age)\n* Who underwent a coronary angioplasty with drug-eluting balloon between January 2010 and December 2025\n* Identified in the institutional procedure database\n\nExclusion Criteria:\n\n* Incomplete or non-available data on the post-procedural clinical follow-up\n* Procedures where other devices were used in combination with drug-eluting balloons.","ALL","18 Years",{"count":65,"type":66},1500,"ESTIMATED","OBSERVATIONAL","Retrospective analysis of data collected in an institutional database of coronary interventions with use of drug-eluting balloons, with a prospective follow-up for major adverse cardiovascular events and living status.",[70,71,72],"Coronary Arterial Disease (CAD)","Restenosis, Coronary","Bifurcation Coronary Disease","2026-04-15",{"date":75,"type":76},"2026-04-20","ACTUAL",{"date":78,"type":76},"2025-06-10",{"date":80,"type":66},"2036-03",{"name":52,"class":6},1]